Ted White, Verrica Pharmaceuticals CEO
'Hands may be tied': FDA slaps Verrica with 3rd CRL due to problems with contract manufacturer
The FDA has rejected Verrica Pharmaceuticals’ skin disease treatment for a third time — and once again the contract manufacturer is to blame.
The biotech emphasized …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
